Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Vomiting in pregnancy. Green Top Guideline
1. Management of
Nausea and Vomiting
of Pregnancy
and
Hyperemesis
Gravidarum
Green-top Guideline, 2016
Prof. Aboubakr Elnashar
Benha University Hospital, Egypt
ABOUBAKR ELNASHAR
3. INTRODUCTION
NVP
up to 80% of pregnant women
one of most common indications for hospital
admission
Defined as
Nausea and/or vomiting
during early pregnancy
where there are no other causes.
ABOUBAKR ELNASHAR
4. HG
Severe form of NVP
0.3–3.6% of pregnant women.
Recurrence rates
15% up to 80%
ABOUBAKR ELNASHAR
5. I. DIAGNOSIS AND ASSESSMENT
NVP should only be diagnosed when
onset in 1st trimester of pregnancy
other causes of N and V have been excluded.
HG diagnosed when there is
Protracted* NVP with
The triad of
1. Weight loss ≥ 5% prepregnancy
2. Dehydration
3. Electrolyte imbalance.
*Prolonged ABOUBAKR ELNASHAR
6. Severity of NVP classified
Pregnancy-Unique Quantification of Emesis (PUQE)
score
An objective and validated index of N and V
ABOUBAKR ELNASHAR
8. Initial clinical assessment and baseline investigations
1. History
1. Previous history of NVP/HG
2. Quantify severity using PUQE score:
N, V,
Hypersalivation, spitting
Loss of weight
Inability to tolerate food and fluids
Effect on quality of life
3. History to exclude other causes:
abdominal pain
urinary symptoms
infection
drug history
chronic Helico bacter pylori infection
ABOUBAKR ELNASHAR
9. 2. Examination
General
T, P, BP, RR
Oxygen saturations
Weight
Signs of dehydration
Signs of muscle wasting
Abdominal
Other examination
as guided by history
ABOUBAKR ELNASHAR
13. Refractory cases OR
History of previous admissions:
1. TFTs:
Exclude hypothyroid/hyperthyroid
2. LFTs:
Exclude hepatitis or gallstones, monitor
malnutrition
3. Calcium and phosphate
4. Amylase:
Exclude pancreatitis
5. ABG:
Exclude metabolic disturbances to monitor severity
ABOUBAKR ELNASHAR
14. Other pathological causes should be excluded by
clinical history, focused examination and investigations.
1. GIT:
Cholecystitis, peptic ulcer, gastroenteritis
hepatitis, pancreatitis
2. Genitourinary:
urinary tract infection or pyelonephritis
3. Metabolic:
4. Neurological
5. Drug-induced
ABOUBAKR ELNASHAR
15. Severe abdominal or epigastric pain
unusual in NVP and HG
may warrant further investigation of
serum amylase levels
abdominal ultrasound
possibly oesophageal gastroduodenoscopy,which
is considered safe in pregnancy.
Chronic infection with Helicobacter pylori
can be associated with NVP and HG
testing for H. pylori antibodies may be considered.
ABOUBAKR ELNASHAR
16. II. TREATMENT
Place
Community management
Mild NVP
managed with antiemetics.
Ambulatory daycare management
Community/primary care measures have failed
PUQE score is less than 13.
ABOUBAKR ELNASHAR
17. Inpatient management
1. Continued N and V and inability to keep down oral
antiemetics
2. Continued N and V associated with
1. ketonuria and/or
2. weight loss (≥5%of body weight), despite oral
antiemetics
3. Confirmed or suspected comorbidity
1. urinary tract infection
2. inability to tolerate oral antibiotics.
ABOUBAKR ELNASHAR
19. First-line antiemetic
Safe and effective
should be prescribed when required for NVP and HG
Antihistamines (H1 receptor antagonists)
Phenothiazines
Risk of oculogyric crises
ABOUBAKR ELNASHAR
20. First drug is not effective.
drugs from different classes
Combinations of different drugs
Persistent or severe HG:
Parenteral or
Rectal route
Ask about previous adverse reactions
If adverse reaction: prompt cessation
use antiemetics with which you are familiar
Women with previous or current NVP or HG
Avoid iron-containing preparations
if these exacerbate the symptoms.
ABOUBAKR ELNASHAR
21. 2nd line antiemetics
Metoclopramide
safe and effective
Risk of
extrapyramidal effects
oculogyric crises
Short-term use (maximum dose of 30 mg in 24 hours or
0.5 mg/kg body weight in 24 hours [whichever is lowest]
and maximum duration of 5 days)
IV doses should be administered by slow bolus
injection over at least 3 minutes to help minimise these
risks.
(Regan et al, 2009)
ABOUBAKR ELNASHAR
22. Ondansetron use in NVP and HG
5-HT3 receptor antagonist
US FDA pregnancy category B:
Animal studies: failed to demonstrate F risk
No adequate and well-controlled studies in
pregnant women.
Safe and effective
(RCOG, 2016)
ABOUBAKR ELNASHAR
23. Ondansetron use in NVP&HG
increased to 13%
No increase of specific birth defects with first-
trimester use
(Parker et al, 2018)
ABOUBAKR ELNASHAR
25. Not recommended
Pyridoxine
1. no association between the degree of NVP and
vit B6 levels
2. Cochrane SR: lack of consistent evidence that
pyridoxine is effective
3. RCT: did not demonstrate any improvement in
nausea
Diazepam
addition reduced nausea
no difference in vomiting
ABOUBAKR ELNASHAR
26. 2. Rehydration
Normal saline
Add potassium chloride in each bag
guided by daily monitoring of electrolytes
The most appropriate IV hydration.
Dextrose infusions
Not appropriate unless
serum sodium levels are normal
Thiamine has been administered.
Urea and serum electrolyte levels
should be checked daily in women requiring IV fluids.
ABOUBAKR ELNASHAR
27. III. PREVENTION OF COMPLICATIONS
1. Severe NVP or HG
Multidisciplinary team
midwives, nurses
dieticians, pharmacists
endocrinologists, gastroenterologists,
psychiatrist.
ABOUBAKR ELNASHAR
28. 2. Histamine H2 receptor antagonists or
proton pump inhibitors
may be used for women developing
gastro-oesophageal reflux disease
oesophagitis or
gastritis.
ABOUBAKR ELNASHAR
29. 2. Thiamine supplementation (vit B1)
either oral or IV
should be given to all women admitted with
prolonged vomiting, especially
before administration of dextrose or parenteral
nutrition.
ABOUBAKR ELNASHAR
30. Wernicke’s encephalopathy
due to vitamin B1 (thiamine) deficiency
Sym:
blurred vision, unsteadiness and
confusion/memory problems/drowsiness
Signs:
nystagmus, ophthalmoplegia, hyporeflexia or
areflexia, gait and/or finger–nose ataxia.
ABOUBAKR ELNASHAR
31. Episodic and of slow onset.
Potentially fatal but reversible medical emergency.
Association with IV dextrose and parenteral nutrition.
Complete remission: 29%
Permanent residual impairment: common.
Pregnancy loss: IUFD and terminations: 48%.
(Chiossi et al, 2006)
ABOUBAKR ELNASHAR
32. 3. Women admitted with HG
Thromboprophylaxis:
low-molecular-weight heparin
unless there are specific contraindications such
as active bleeding.
can be discontinued upon discharge.
ABOUBAKR ELNASHAR
33. 4. Enteral and parenteral nutrition
When all other medical therapies have failed
ABOUBAKR ELNASHAR
34. 5. Termination of pregnancy
Occasionally, HG or its treatment may lead to life-
threatening illness
termination of the pregnancy is seen as the only
option.
Initiation of a prompt and responsive treatment plan
may reduce this.
ABOUBAKR ELNASHAR
35. All therapeutic measures
should have been tried before offering termination
of pregnancy.
10% of pregnancies complicated by HG
Many of these women have not been offered the full
range of treatments available
10% had been offered steroids.
(Al-Ozairi et al, 2009)
ABOUBAKR ELNASHAR
36. Treatment options before deciding that the only option
is termination of the pregnancy
Antiemetics
Corticosteroids
Enteral and parenteral feeding
Correction of electrolyte or metabolic disturbances
Decision
multidisciplinary,
psychiatric opinion
with documentation of therapeutic failure.
ABOUBAKR ELNASHAR
37. 808 women who terminated their pregnancies
secondary to HG
(Poursharif et al, 2007)
Prominent reasons
Inability to care for the family and self: 66.7%
Fear that they or their baby could die: 51.2%
Fear the baby would be abnormal: 22%
ABOUBAKR ELNASHAR
38. V. FOLLOW-UP
1. ANTENATAL
An individualised management plan
Severe NVP or HG who have continued symptoms
into the late second or the third trimester:
serial scans to monitor fetal growth.
ABOUBAKR ELNASHAR
39. 2. Postnatal
A woman’s quality of life can be adversely affected
Assess a woman’s mental health status during
the pregnancy and postnatally
Refer for psychological support if necessary.
ABOUBAKR ELNASHAR
40. 3. Future pregnancies
Women with previous HG should be advised that
there is a risk of recurrence in future pregnancies.
Early use of
lifestyle/dietary modifications
Antiemetics
that were found to be useful in the index
pregnancy to reduce the risk of NVP and HG in
the current pregnancy.
ABOUBAKR ELNASHAR
42. You can get this lecture and 392
lecture from:
1.My scientific page on Face book:
Aboubakr Elnashar Lectures.
https://www.facebook.com/groups/2277
44884091351/
2.Slide share web site
3. elnashar53@hotmail.com
4.My clinic: Althwara st, Mansura, Egypt
ABOUBAKR ELNASHAR